Search results

Showing 1 – 32 of 32 results.

Curated

Restricted

Abstinence Reinforcing Contingency Management to Suppress HIV Viral Load (Project First), New York City, 2012 (ICPSR 39785)

Released/updated on: 2026-04-20

Geographic coverage: New York City, United States, New York (state)

This study is part of the Seek, Test, Treat and Retain (STTR) Collaboration Project that involved over twenty studies in the fields of HIV and drug abuse. All studies were independently developed, but were chosen for the collaboration because they focused on one or more steps of the HIV treatment cascade: Seek, Test, Treat and Retain. As part of STTR Collaboration Project, the studies were grouped into Criminal Justice-related studies and Vulnerable Population-related studies. The data collected by these studies included twelve common domains (e.g., Demographic characteristics, Mental Health) in each of which a shared questionnaire or instrument was taken up by the studies and adapted to fit the study.

Using a randomized controlled study design, this study tested the efficacy of an abstinence-reinforcing CM intervention compared with a control condition (performance feedback) on HIV viral load (VL) suppression. The intervention CM group could receive up to $1320 in vouchers over the 16-week intervention based on drug-free urine. Participants were followed for 28 weeks (44 visits), with research visits occurring twice weekly during the Baseline Period (weeks 1-4, visits 1-8) and Intervention Period (weeks 5-20, visits 9-40), then every two weeks during the Post-Intervention Period (weeks 21-28, visits 41-44).

Curated

Arrestee Drug Abuse Monitoring (ADAM) Program in the United States, 2001 (ICPSR 3688)

Released/updated on: 2006-03-30

Geographic coverage: North Carolina, Oklahoma City, Detroit, Charlotte, Indiana, Tucson, Albuquerque, Spokane, Utah, San Jose, New York City, San Diego, Arizona, Las Vegas, Sacramento, Seattle, California, Pennsylvania, Tulsa, Laredo, Iowa, Illinois, Texas, Portland (Oregon), Indianapolis, Oregon, United States, Oklahoma, Alabama, Cleveland, Washington, Nebraska, Albany (New York), Omaha, Minneapolis, Colorado, Honolulu, Missouri, New Orleans, Alaska, Phoenix, Denver, Salt Lake City, Dallas, Nevada, Des Moines, San Antonio, Chicago, Hawaii, Minnesota, Kansas City (Missouri), New York (state), Birmingham, Michigan, New Mexico, Louisiana, Anchorage, Ohio, Philadelphia

Time period: 2001-01-01--2001-12-31

The goal of the Arrestee Drug Abuse Monitoring (ADAM) Program is to determine the extent and correlates of illicit drug use in the population of booked arrestees in local areas. Data were collected in 2001 at four separate times (quarterly) during the year in 33 metropolitan areas in the United States. The ADAM program adopted a new instrument in 2000 in adult booking facilities for male (Part 1) and female (Part 2) arrestees. Data from arrestees in juvenile detention facilities (Part 3) continued to use the juvenile instrument from previous years, extending back through the DRUG USE FORECASTING series (ICPSR 9477). The ADAM program in 2001 also continued the use of probability-based sampling for male arrestees in adult facilities, which was initiated in 2000. Therefore, the male adult sample includes weights, generated through post-sampling stratification of the data. For the adult files, variables fell into one of eight categories: (1) demographic data on each arrestee, (2) ADAM facesheet (records-based) data, (3) data on disposition of the case, including accession to a verbal consent script, (4) calendar of admissions to substance abuse and mental health treatment programs, (5) data on alcohol and drug use, abuse, and dependence (6) drug acquisition data covering the five most commonly used illicit drugs, (7) urine test results, and (8) weights. The juvenile file contains demographic variables and arrestee's self-reported past and continued use of 15 drugs, as well as other drug-related behaviors.

Curated

Arrestee Drug Abuse Monitoring (ADAM) Program in the United States, 2002 (ICPSR 3815)

Released/updated on: 2006-03-30

Geographic coverage: North Carolina, Oklahoma City, Charlotte, Indiana, Tucson, Albuquerque, Spokane, Utah, San Jose, New York City, San Diego, Arizona, Las Vegas, Sacramento, Seattle, California, Washington, District of Columbia, Pennsylvania, Tulsa, Laredo, Iowa, Illinois, Texas, Portland (Oregon), Georgia, Indianapolis, Oregon, United States, Oklahoma, Rio Arriba, Alabama, Cleveland, Washington, Nebraska, Albany (New York), Omaha, Minneapolis, Woodbury, Atlanta, Colorado, Honolulu, New Orleans, Alaska, Phoenix, Denver, Salt Lake City, Dallas, Nevada, Des Moines, San Antonio, Chicago, Hawaii, Minnesota, New York (state), Birmingham, New Mexico, Louisiana, Anchorage, Ohio, Los Angeles, Philadelphia

Time period: 2002-01-01--2002-12-31

The goal of the Arrestee Drug Abuse Monitoring (ADAM) Program is to determine the extent and correlates of illicit drug use in the population of booked arrestees in local areas. Data were collected in 2002 at four separate times (quarterly) during the year in 36 metropolitan areas in the United States. The ADAM program adopted a new instrument in 2000 in adult booking facilities for male (Part 1) and female (Part 2) arrestees. Data from arrestees in juvenile detention facilities (Part 3) continued to use the juvenile instrument from previous years, extending back through the DRUG USE FORECASTING series (ICPSR 9477). The ADAM program in 2002 also continued the use of probability-based sampling for male arrestees in adult facilities, which was initiated in 2000. Therefore, the male adult sample includes weights, generated through post-sampling stratification of the data. For the adult files, variables fell into one of eight categories: (1) demographic data on each arrestee, (2) ADAM facesheet (records-based) data, (3) data on disposition of the case, including accession to a verbal consent script, (4) calendar of admissions to substance abuse and mental health treatment programs, (5) data on alcohol and drug use, abuse, and dependence, (6) drug acquisition data covering the five most commonly used illicit drugs, (7) urine test results, and (8) weights. The juvenile file contains demographic variables and arrestee's self-reported past and continued use of 15 drugs, as well as other drug-related behaviors.

Curated

Arrestee Drug Abuse Monitoring (ADAM) Program in the United States, 2003 (ICPSR 4020)

Released/updated on: 2006-03-30

Geographic coverage: North Carolina, Oklahoma City, Charlotte, Indiana, Tucson, Albuquerque, Spokane, Utah, San Jose, New York City, San Diego, Arizona, Las Vegas, Boston, Sacramento, Seattle, California, Florida, Pennsylvania, Tulsa, Iowa, Illinois, Texas, Portland (Oregon), Georgia, Tampa, Indianapolis, Oregon, United States, Oklahoma, Rio Arriba, Alabama, Cleveland, Washington, Nebraska, Albany (New York), Omaha, Minneapolis, Woodbury, Atlanta, Massachusetts, Colorado, Honolulu, New Orleans, Alaska, Phoenix, Denver, Salt Lake City, Dallas, Nevada, Des Moines, District of Columbia, San Antonio, Chicago, Hawaii, Minnesota, New York (state), Birmingham, Miami, New Mexico, Louisiana, Anchorage, Ohio, Los Angeles, Philadelphia, Houston

Time period: 2003-01-01--2003-12-31

The goal of the Arrestee Drug Abuse Monitoring (ADAM) Program is to determine the extent and correlates of illicit drug use in the population of booked arrestees in local areas. Data were collected in 2003 up to four separate times (quarterly) during the year in 39 metropolitan areas in the United States. The ADAM program adopted a new instrument in 2000 in adult booking facilities for male (Part 1) and female (Part 2) arrestees. The ADAM program in 2003 also continued the use of probability-based sampling for male arrestees in adult facilities, which was initiated in 2000. Therefore, the male adult sample includes weights, generated through post-sampling stratification of the data. For the adult male and female files, variables fell into one of eight categories: (1) demographic data on each arrestee, (2) ADAM facesheet (records-based) data, (3) data on disposition of the case, including accession to a verbal consent script, (4) calendar of admissions to substance abuse and mental health treatment programs, (5) data on alcohol and drug use, abuse, and dependence, (6) drug acquisition data covering the five most commonly used illicit drugs, (7) urine test results, and (8) for males, weights.

Curated

Arrestee Drug Abuse Monitoring II in the United States, 2012 (Restricted Use) (ICPSR 34821)

Released/updated on: 2013-08-29

Geographic coverage: New York City, Sacramento, United States, Chicago, Atlanta, Illinois, Colorado, Denver, California, Georgia, New York (state)

Time period: 2012-04-30--2012-07-29

The Arrestee Drug Abuse Monitoring II, 2012 is a collection of interview and bioassay data provided by over 3000 arrestees from five county sites within the United States. Under the sponsorship of the Office of National Drug Control Policy (ONDCP), the ADAM II program monitors drug use and related behaviors (treatment experiences, housing stability, drug market activity, age at first use, employment, etc.) in a probability based sample of male adult arrestees within 48 hours of their arrest. The five ADAM II sites for 2012 were: Atlanta, GA (Fulton County and the City of Atlanta); Chicago, IL (Cook County); Denver, CO (Denver County); New York, NY (Borough of Manhattan); and Sacramento, CA (Sacramento County). The 2012 survey represents the sixth year of ADAM II and includes data from 1,938 interviews and 1,736 urine tests that were conducted at the five ADAM II sites over a 21-day period, between April 30 and July 29, 2012. The samples from these sites were weighted to represent over 14,000 arrests of adult males in the five counties. ADAM II data include official records, arrestee responses from a 20-minute face-to-face interview, and results from voluntary urine samples which tested for the presence of nine different drugs. Identifying information on the arrestees was not retained or shared with law enforcement. Demographic variables include age, gender, race, arrest date and time, county of arrest, number and type(s) of offense(s), education, work status, and language of interview.

Curated

Arrestee Drug Abuse Monitoring II in the United States, 2013 (Restricted Use) (ICPSR 35169)

Released/updated on: 2014-08-01

Geographic coverage: New York City, Sacramento, United States, Chicago, Atlanta, Illinois, Colorado, Denver, California, Georgia, New York (state)

Time period: 2013-05-05--2013-07-28

The Arrestee Drug Abuse Monitoring II, 2013 is a collection of interview and bioassay data provided by over 3000 arrestees from five county sites within the United States. Under the sponsorship of the Office of National Drug Control Policy (ONDCP), the ADAM II program monitors drug use and related behaviors (treatment experiences, housing stability, drug market activity, age at first use, employment, etc.) in a probability based sample of male adult arrestees within 48 hours of their arrest. The five ADAM II sites for 2013 were: Atlanta, GA (Fulton County and the City of Atlanta); Chicago, IL (Cook County); Denver, CO (Denver County); New York, NY (Borough of Manhattan); and Sacramento, CA (Sacramento County). The 2013 survey represents the seventh year of ADAM II and includes data from 1,900 interviews and 1,681 urine tests that were conducted at the five ADAM II sites over a 21-day period, between May 5, 2013 and July 28, 2013. ADAM II data include official records, arrestee responses from a 20-minute face-to-face interview, and results from voluntary urine samples which tested for the presence of nine different drugs. Identifying information on the arrestees was not retained or shared with law enforcement. Demographic variables include age, gender, race, citizenship, marital status, arrest date and time, county of arrest, number and type(s) of offense(s), education, work status, and language of interview.

Curated

Arrestee Drug Abuse Monitoring Program II in the United States, 2007 (ICPSR 25821)

Released/updated on: 2010-01-28

Geographic coverage: North Carolina, Oregon, District of Columbia, Charlotte, Sacramento, Indiana, United States, Chicago, Minnesota, California, New York (state), New York City, Minneapolis, Atlanta, Illinois, Colorado, Portland (Oregon), Denver, Georgia, Indianapolis

Time period: 2007-04-01--2007-09-01

The Arrestee Drug Abuse Monitoring (ADAM) II program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, the ONDCP and Abt Associates have initiated a new data collection that replicates the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. A total of 8,296 arrestees were interviewed during the second and third quarters of 2007. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. The Arrestee Drug Abuse Monitoring (ADAM) II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.

Curated

Arrestee Drug Abuse Monitoring Program II in the United States, 2008 (ICPSR 27221)

Released/updated on: 2010-03-31

The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc. have initiated a new data collection that replicates the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implements two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collects data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. Data collection has been conducted across two back-to-back quarters in each of 10 counties from a county-based representative sample of 250 male arrestees per quarter for a total of 500 arrestees annually per site or a total of 5,000 arrestees across sites annually. A total of 7,717 arrestees were interviewed during the second and third quarters of 2008. Collection occurs in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2007 and ending March 31, 2008. Additional data collection periods were optioned by ONDCP, and subsequent cycles of back-to-back data collection (not yet available) began April 1, 2008. Participation is voluntary and confidential, and the procedures include a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.

Curated

Arrestee Drug Abuse Monitoring Program II in the United States, 2009 (ICPSR 30061)

Released/updated on: 2011-02-24

The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc., initiated a new data collection that replicated the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. A total of 7,794 arrestees were interviewed during the second and third quarters of 2009. Collection occurred in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2009, and ending September 30, 2009. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.

Curated

Arrestee Drug Abuse Monitoring Program II in the United States, 2010 (ICPSR 32321)

Released/updated on: 2011-11-04

The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc., initiated a new data collection that replicated the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. A total of 8,332 arrestees were interviewed during the second and third quarters of 2010. Collection occurred in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2010, and ending September 30, 2010. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.

Curated

Simple Crosstabs

The Community Vulnerability and Responses to Drug-User-Related HIV/AIDS, 1990-2013 [96 Metropolitan Statistical Areas, United States] (ICPSR 36575)

Released/updated on: 2017-08-08

Geographic coverage: North Carolina, Milwaukee, Indiana, Ocean (New Jersey), Fort Worth, Cincinnati, Austin, Monmouth (New Jersey), Utah, San Jose, Rock Hill, Gastonia, San Diego, Columbus (Ohio), Syracuse, Springfield (Massachusetts), North Little Rock (Arkansas), Arizona, Las Vegas, Arlington, Springfield (Ohio), Boston, San Bernardino, Providence, Seattle, Kentucky, St. Petersburg, Bethlehem, Niagara Falls (New York), Nashville, California, Florida, Delaware, Hunterdon (New Jersey), Boca Raton (Florida), Troy, Knoxville, Mississippi, Fresno, New Haven, Sarasota, Illinois, Newark, Georgia, Little Rock, Virginia, Maryland, Norfolk, Virginia Beach, Suffolk County (New York), United States, Oklahoma, Grand Rapids, Louisville, Waukesha (Wisconsin), Arkansas, Washington, South Carolina, Albany (New York), Wichita, Mesa (Arizona), Carlisle (Pennsylvania), Fall River, Massachusetts, Missouri, Winston-Salem, Holland (Michigan), New Orleans, Scranton, Denver, Salt Lake City, Harrisburg, Dallas, St. Louis, Nevada, Schenectady, Allentown, Raleigh, San Antonio, Muskegon, St. Paul, Clearwater, Hawaii, Rochester (New York), Passaic, Ventura (California), Birmingham, Michigan, Lebanon, Baltimore, New Mexico, Orlando, Louisiana, Toledo, Middlesex (New Jersey), Philadelphia, Riverside, Oklahoma City, Akron, Greensboro, Detroit, Charlotte, High Point, Tucson, Albuquerque, Everett, Oakland, Bakersfield, New York City, Somerset (New Jersey), Petersburg, Memphis, Ogden, Jacksonville, Buffalo, Pittsburgh, Nassau (New York), Orange County (California), Sacramento, El Paso, Greenville, Kansas, Meriden, Pennsylvania, Tulsa, Chapel Hill (North Carolina), West Palm Beach, Iowa, Texas, Lorain, Portland (Oregon), Hazleton, Tampa, Durham, San Marcos (Texas), Indianapolis, Richmond, Oregon, Warwick, Bergen (New Jersey), Newport News, Ann Arbor, Alabama, Cleveland, Dayton, Nebraska, Omaha, Warren, West Virginia, Elyria, Tacoma, Minneapolis, Youngstown, Atlanta, Honolulu, Phoenix, Bradenton, Wilmington (Delaware), Gary, District of Columbia, Rhode Island, Vancouver (Washington), Lodi (California), Chicago, Fort Lauderdale, Wilkes-Barre, Minnesota, Kansas City (Missouri), Bellevue, New York (state), Anderson, New Jersey, Miami, San Francisco, Charleston (South Carolina), Jersey City, Long Beach, Spartanburg (South Carolina), New Hampshire, Easton, Ohio, Los Angeles, Hartford, Stockton, Houston

Time period: 1990-01-01--2013-01-01

The Community Vulnerability and Responses to Drug-User-Related HIV/AIDS, 1990-2013 [96 Metropolitan Statistical Areas, United States] study (CVAR) was a research study of why large United States Metropolitan Statistical Areas (MSAs) vary over time in their vulnerability to HIV/AIDS among drug users and in MSA responses to HIV/AIDS. This collection contains estimates of HIV prevalence among people who injected drugs (PWID) and among sub-populations of PWID. This collection is comprised of ten datasets with differing amounts of variables and provides trend data that describe the following:

Epidemiologic outcomes including population prevalence of PWIDs and Non-injecting drug users (NIDUs), and particularly their prevalence among youth; and, among PWIDs, HIV prevalence, late-diagnosis HIV cases, and AIDS incidence and mortality.
Implementation of evidence-based drug-related interventions including drug abuse treatment, syringe exchange, HIV counseling and testing.
Implementation of non-evidence-based drug-related interventions including incarceration and arrests of drug users.

The collection contains data on the MSA sub-populations including Black, Hispanic, White and "other" race categories. In addition, some statistics are presented in age range categories such as ages 15-29, 30-64 and 15-64.

Curated

Contextualizing and Responding to HIV Risk Behaviors among Black Drug Offenders, New York, 2016 (ICPSR 37590)

Released/updated on: 2020-03-05

Geographic coverage: New York City, United States

Time period: 2016-07-05--2016-12-21

The purpose of this study was to pilot test the potential for improvement in antiretroviral medication adherence of an adapted group-based, multi-session, community-based Antiretroviral Therapy (ART) adherence and risk reduction intervention, Project ADHerence Education and Risk Evaluation (ADHERE). Project ADHERE was compared to a single-session group-based medication adherence intervention, Medication Adherence and Care Engagement (MACE). A secondary aim was to examine the impact of Project ADHERE on HIV risk behaviors (i.e., illicit drug use and unprotected sexual behavior).

Formerly incarcerated Black drug offenders are at an elevated risk for HIV infection. Despite substantial research expressing the need for HIV prevention services for ex-offenders postrelease, this population has limited access to quality programming and services related to HIV risk reduction. This study seeks to inform and adapt an HIV risk reduction intervention to address the needs of formerly incarcerated Black drug offenders who are being released from prisons in the New York City metropolitan area. The study utilizes qualitative and quantitative methods to inform and adapt an HIV prevention intervention for this study population.

Curated

Crack, Powder Cocaine, and Heroin: Drug Purchase and Use Patterns in Six Cities in the United States, 1995-1996 (ICPSR 2564)

Released/updated on: 2012-08-22

Geographic coverage: New York City, Oregon, District of Columbia, San Diego, San Antonio, United States, Chicago, Illinois, Texas, Portland (Oregon), California, New York (state)

Time period: 1995-01-01--1996-01-01

This study was designed to address the practical and policy implications of various drug market participation patterns. In 1995, the Office of National Drug Control Policy (ONDCP) and the National Institute of Justice (NIJ) collaborated on a project called the Procurement Study. This study was executed as an addendum to NIJ's Drug Use Forecasting (DUF) program (DRUG USE FORECASTING IN 24 CITIES IN THE UNITED STATES, 1987-1997 [ICPSR 9477]) with the goal of extending previous research in which heroin users were interviewed on various aspects of drug market activity. The present study sought to explore additional features of drug market participation and use, both within and across drug types and cities, and included two additional drugs -- powder cocaine and crack cocaine. Data were collected from recently arrested users of powder cocaine, crack cocaine, and heroin in six DUF cities (Chicago, New York, Portland, San Diego, San Antonio, and Washington, DC). Each of the three files in this collection, Crack Data (Part 1), Heroin Data (Part 2), and Powder Cocaine Data (Part 3), is comprised of data from a procurement interview, urine test variables, and a DUF interview. During the procurement interview, information was collected on purchase and use patterns for specific drugs. Variables from the procurement interview include the respondent's method of using the drug, the term used to refer to the drug, whether the respondent bought the drug in the neighborhood, the number of different dealers the respondent bought the drug from, how the respondent made the connection with the dealer (i.e., street, house, phone, beeper, business/store, or friends), their main drug source, whether the respondent went to someone else if the source was not available, how the respondent coped with not being able to find drugs to buy, whether the respondent got the drug for free, the means by which the respondent obtained money, the quantity and packaging of the drug, and the number of minutes spent searching for, traveling to, and waiting for their last purchase. Urine tests screened for the presence of ten drugs, including marijuana, opiates, cocaine, PCP, methadone, benzodiazepines (Valium), methaqualone, propoxyphene (Darvon), barbiturates, and amphetamines (positive test results for amphetamines were confirmed by gas chromatography). Data from the DUF interview provide detailed information about each arrestee's self-reported use of 15 drugs. For each drug type, arrestees were asked whether they had ever used the drug, the age at which they first used the drug, whether they had used the drug within the past three days, how many days they had used the drug within the past month, whether they had ever needed or felt dependent on the drug, and whether they were dependent on the drug at the time of the interview. Data from the DUF interview instrument also included alcohol/drug treatment history, information about whether arrestees had ever injected drugs, and whether they were influenced by drugs when the crime that they were charged with was committed. The data also include information about whether the arrestee had been to an emergency room for drug-related incidents and whether he or she had had prior arrests in the past 12 months. Demographic data include the age, race, sex, educational attainment, marital status, employment status, and living circumstances of each respondent.

Curated

Simple Crosstabs

Criminal Justice Drug Abuse Treatment Studies (CJ-DATS): Transitional Care Management (TCM), Increasing Aftercare Participation for Parolees, 2004-2008 [United States] (ICPSR 31621)

Released/updated on: 2014-03-14

Geographic coverage: New York City, United States, Connecticut, Kentucky, Los Angeles, Hartford, California, New York (state), Lexington

Time period: 2004-11-01--2008-05-01

In an effort to increase participation in community aftercare treatment for substance-abusing offenders who have paroled from prison, the Transitional Case Management (TCM) intervention tested a model of strengths-based case management consisting of (1) completion by the inmate of a strengths and goals assessment as part of discharge planning, (2) a telephone conference call that included the inmate and people central to the inmate's aftercare plan (including the parole officer), and (3) strengths case management for 12 weeks in the community to promote treatment participation and increase the client's access to needed services. (For a more detailed description, see Prendergast Law and Cartier, 2008). With four CJ-DATS Research Centers participating, the study randomized 812 prison treatment clients to the Transitional Case Management condition or to the Standard Referral condition. Detailed assessments occurred at baseline and at three and nine months following release to parole. Data from treatment and criminal justice records, including costs, were also collected. Treatment and criminal justice staff completed surveys on agency collaboration and cooperation. Respondents were asked questions regarding the barriers to treatment/recovery, education/job training, relationships, finance, living arrangement/housing, health and documentation. They were also asked question related to whether they needed or received certain services. Other variables included socio-demographic and family background, peer relation and criminal history, health and psychological status, drug and treatment history.

Curated

Dynamics of Retail Methamphetamine Markets in New York City, 2007-2009 (ICPSR 29821)

Released/updated on: 2014-01-06

Geographic coverage: New York City, United States, New York (state)

Time period: 2007-01-01--2009-12-31

The study was conducted to provide information about markets for, distribution of, and use of methamphetamine in New York City, both inside and outside of the MSM (men who have sex with men)/gay community. The study used Respondent Driven Sampling to recruit 132 methamphetamine market participants. Each respondent participated in a one to two hour structured interview combining both qualitative and quantitative responses. Each respondent was invited to recruit three additional eligible participants. Data collected included demographics, social network data, the respondent's market participation in obtaining and providing methamphetamine, consumption of methamphetamine, and experience with the criminal justice system and crime associated with participation in methamphetamine markets.

Curated

Evaluation of the Adolescent Portable Therapy (APT) Program [New York City], 2001-2004 (ICPSR 4299)

Released/updated on: 2005-11-04

Geographic coverage: New York City, United States, New York (state)

Time period: 2001-01-01--2004-01-01

This study contains data collected for an evaluation of the Adolescent Portable Therapy (APT) Program, which provided family-based drug treatment services to adolescents involved with the New York City juvenile justice system on charges of Persons In Need of Supervision (PINS) or delinquency. The program aimed to improve five core areas of the young peoples' lives: substance use, mental health, schooling, family functioning, and recidivism. Recruitment for the study occurred at juvenile detention facilities in New York City. Intake staff conducted screening interviews with the detainees. Those who reported using substances at least 30 times in the previous 30 days, or who met Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM IV) criteria for substance abuse or dependence were eligible for selection. After the respondents and their families consented to participate, the respondents were randomly assigned to treatment and control groups. The treatment group went on to receive services from APT, while control group subjects received no APT services but had access to all other standard facilities and community based services. The evaluation participants were interviewed at four time points: at intake into the study in the juvenile detention facilities (baseline), three months after release from detention (T1), nine months after release from detention (T2), and 15 months after release from detention (T3). Whenever subjects were interviewed outside of a detention facility for T1, T2, and T3, study staff attempted to collect urine samples which were tested for marijuana, cocaine, amphetamines, phencyclidine (PCP), and opiates. Topics covered by the interviews included substance use and treatment, physical health, risk behaviors and disease prevention, mental and emotional health, living situation and environment, crime and legal issues, school, work, income, and demographic characteristics.

Curated

Evaluation of the Health Link Program [New York City]: The Community Reintegration Model to Reduce Substance Abuse Among Jail Inmates, 1997-2002 (ICPSR 3978)

Released/updated on: 2004-08-20

Geographic coverage: New York City, United States, New York (state)

Time period: 1997-01-01--2002-01-01

This evaluation study, funded by The Robert Wood Johnson Foundation, was designed to provide a rigorous assessment of the effects of making Health Link's community-based services available to former inmates of New York City's jail system at Rikers Island. The goal of the Health Link Project was to promote healthy reintegration of persons leaving Rikers into their communities by (1) providing direct services to incarcerated and formerly incarcerated clients, (2) assisting community organizations that served this population, (3) establishing linkages between organizations, and (4) strengthening linkages between them and public agencies. The signature component of Health Link was case management in the community. Meeting with clients after their release from jail, caseworkers provided a support structure, made referrals to services, offered crisis intervention and counseling, and served as advocates for clients. Only adult females and adolescent males were included in the study. Eligible inmates who volunteered for the evaluation study were assigned to one of two groups: the Jail-and-Community Services group (JC group) or the Jail Services Only group (J group). JC group members were eligible for Health Link's intensive discharge planning and community case management services, while J group members were eligible for less intensive discharge planning services and ineligible for Health Link's community case management services. Evaluation subjects initially completed an intake questionnaire, which collected information on age, race, Hispanic origin, ethnicity, place and type of residence, family relations, criminal background, employment and education, substance abuse, health and medical history, sexual at-risk behavior and reproductive health, and history of trauma. Follow-up interviews were conducted, on average, about 15 months after release from jail, a sufficient time to observe the 12-month period for which clients were eligible for community-based services. Topics covered in the follow-up 12 Month Questionnaire included involvement in the criminal justice system, criminal activity, substance abuse, participation in substance abuse treatment programs, education and employment outcomes, health status, access to and utilization of health care services, sexual activity and HIV risk, housing, and involvement with family and community. Subjects who were not incarcerated at the time of their follow-up interview were asked to voluntarily provide hair samples, which were tested for metabolites of cocaine, opiates, PCP, methamphetamine, and marijuana.

Curated

Evaluation of the Midtown Community Court in New York City, 1992-1994 (ICPSR 2311)

Released/updated on: 2006-03-30

Geographic coverage: New York City, United States, New York (state)

Time period: 1992-01-01--1994-01-01

In October 1993, the Midtown Community Court opened as a three-year demonstration project designed to forge links with the community in developing a problem-solving approach to quality-of-life offenses. The problems that this community-based courthouse sought to address were specific to the court's midtown New York City location: high concentration of quality-of-life crimes, broad community dissatisfaction with court outcomes, visible signs of disorder, and clusters of persistent high-rate offenders with serious problems, including addiction and homelessness. This study was conducted to evaluate how well the new court was able to dispense justice locally and whether the establishment of the Midtown Community Court made a difference in misdemeanor case processing. Data were collected at two time periods for a comparative analysis. First, a baseline dataset (Part 1, Baseline Data) was constructed from administrative records, consisting of a ten-percent random sample of all nonfelony arraignments in Manhattan during the 12 months prior to the opening of the Midtown Community Court. Second, comparable administrative data (Part 2, Comparison Data) were collected from all cases arraigned at the Midtown Court during its first 12 months of operation, as well as from a random sample of all downtown nonfelony arraignments held during this same time period. Both files contain variables on precinct of arrest, arraignment type, charges, bonds, dispositions, sentences, total number of court appearances, and total number of warrants issued, as well as prior felony and misdemeanor convictions. Demographic variables include age, sex, and race of offender.

Curated

Harlem Longitudinal Study of Urban Black Youth, 1968 United States (ICPSR 121)

Released/updated on: 2008-03-26

Geographic coverage: New York City, Harlem, United States

This dataset is housed at the Murray Research Center at Harvard University's Radcliffe Institute for Advanced Study. This is a 26-year longitudinal study of physical, psychological, and social aspects of health among a representative community sample of African-American adolescents, aged 12 to 18, residing in Central Harlem, New York City. Data were collected in five waves: 1968-1970, 1975-1976, 1983-1984, 1989-1990, and 1993-1994. In 1968, there were 668 respondents aged 12-17, and in 1994, when respondents were aged 35-41, 347 remained in the study. Along with other health issues, later waves assessed patterns of non-medical related drug use and HIV-related knowledge, attitudes, and behaviors. In order to apply to use Murray Center data, one must register as a Murray Center user and complete an Application for the Use of Data form.

Curated

Modeling Impacts of Policing Initiatives on Drug and Criminal Careers of Arrestees in New York City, New York, 1999 (ICPSR 3604)

Released/updated on: 2006-03-30

Geographic coverage: New York City, United States, New York (state)

This study sought to understand the accuracy and validity of arrestee self-reports of drug use and the overall contact of arrestees with the criminal justice system, with a secondary focus on how arrestee self-reports of drug use correspond to urinalysis results. Moreover, this study investigated whether arrestees were aware of the New York City Police Department's Quality-of-Life (QOL) policing efforts and whether they had changed their criminal behavior as a result. A QOL Policing Supplement, designed to explore new means of evaluating police behavior, was administered to all adult arrestees in the five boroughs of New York City (Bronx, Brooklyn, Manhattan, Staten Island, and Queens) who had completed an Arrestee Drug Abuse Monitoring (ADAM) program interview, provided a urine specimen, and were willing to answer additional questions concerning QOL policing. Part 1, Policing Study Data, is a large integrated dataset containing all of the variables derived from the 1999 ADAM interviews, the Policing Supplement instrument, and administrative records data from the Criminal Justice Agency (CJA) and the New York State Division of Criminal Justice Services. This dataset is linked, via an anonymous case number, to Part 2, Arrestee Criminal History Data, which contains each arrestee's official criminal history.

Curated

Monitoring Drug Epidemics and the Markets That Sustain Them, Arrestee Drug Abuse Monitoring (ADAM) and ADAM II Data, 2000-2003 and 2007-2010 (ICPSR 33201)

Released/updated on: 2012-12-13

Time period: 2000-01-01--2003-01-01, 2007-01-01--2010-01-01

This study examined trends in the use of five widely abused drugs among arrestees at 10 geographically diverse locations from 2000 to 2010: Atlanta, Charlotte, Chicago, Denver, Indianapolis, Manhattan, Minneapolis, Portland Oregon, Sacramento, and Washington DC. The data came from the Arrestee Drug Abuse Monitoring Program reintroduced in 2007 (ADAM II) and its predecessor the ADAM program. ADAM data included urinalysis results that provided an objective measure of recent drug use, provided location specific estimates over time, and provided sample weights that yielded unbiased estimates for each location. The ADAM data were analyzed according to a drug epidemics framework, which has been previously employed to understand the decline of the crack epidemic, the growth of marijuana use in the 1990s, and the persistence of heroin use. Similar to other diffusion of innovation processes, drug epidemics tend to follow a natural course passing through four distinct phases: incubation, expansion, plateau, and decline. The study also searched for changes in drug markets over the course of a drug epidemic.

Curated

Monitoring Drug Markets in Manhattan [New York City], With the Arrestee Drug Abuse Monitoring (ADAM) Program, 1998-2002 (ICPSR 22381)

Released/updated on: 2009-06-03

Geographic coverage: New York City, United States, New York (state)

Time period: 1998-01-01--2002-01-01

The purpose of the study was to determine how much Manhattan (New York City) arrestees surveyed by the Arrestee Drug Abuse Monitoring (ADAM) program spend on drug expenses. The program obtained both self-report and urinalysis data from a total of 5,210 Manhattan arrestees surveyed by the ADAM program from 1998 to 2002. The principal investigators developed a formula for an episodic estimator of a respondent's drug expense for cash, noncash, and cash-combination transactions. The dataset contains a total of 267 variables relating to Manhattan arrestees' demographics, interview information, criminal history, urinalysis test results, drug use, drug market transactions, and drug expenses.

Curated

National Supported Work Evaluation Study, 1975-1979: Public Use Files (ICPSR 7865)

Released/updated on: 2009-02-02

Geographic coverage: United States, Chicago, California, Oakland, New York (state), New Jersey, Pennsylvania, New York City, Atlanta, Illinois, Connecticut, Hartford, Georgia, Wisconsin, Philadelphia

Time period: 1975-01-01--1979-01-01

This study is an evaluation of the National Supported Work Demonstration project, a transitional, subsidized work experience program for four target groups of people with longstanding employment problems: ex-offenders, former drug addicts, women who were long-term recipients of welfare benefits, and school dropouts, many with criminal records. The program provided up to 12-18 months of employment to about 10,000 individuals at 15 locations across the country for four years. In ten of these sites -- Atlanta, Chicago, Hartford, Jersey City, Newark, New York, Philadelphia, Oakland, San Francisco, and Wisconsin, 6,600 eligible applicants were randomly assigned either to experimental groups (offered a job in supported work) or to control groups, and an evaluation was conducted on the effects of the Supported Work Program. At the time of enrollment, each respondent was given a retrospective baseline interview, generally covering the previous two years, followed by up to four follow-up interviews scheduled at nine-month intervals. Two public use files were originally distributed for this data collection: Supported Work Employment and Earnings File, and Supported Work Deviant Behavior File. Each file contained data for up to five interviews, a cross-document dataset and an Aid to Families with Dependent Children (AFDC) recipients follow-up. The Employment and Earnings File contains data from all interview modules except the drug and crime sections, and the Deviant Behavior File contains all variables on the Employment and Earnings File as well as additional information on drugs and crime. Aid to Families with Dependent Children (AFDC) recipients were further asked about children in school and welfare participation, while all non-AFDC respondents were questioned about any extralegal activities. Demographic items specify age, sex, race, marital status, education, number of children, employment history, job search, job training, mobility, household income, welfare assistance, housing, military discharge status, and drug use. Each respondent has up to six logical, fixed-length records, with each record corresponding to a completed interview (up to five) and one additional short "cross-document" record. A User's Guide describing the collection and its components is available and should be read before the collection or any part of it is ordered.

Curated

Restricted

Peer-Driven Intervention to Seek, Test, and Treat Heterosexuals at High Risk for HIV, New York City, 2011-2016 (ICPSR 39781)

Released/updated on: 2026-04-14

Geographic coverage: New York City, United States, Brooklyn, New York (state)

Time period: 2012-04-01--2016-04-01, 2015-02-01--2016-08-01

This study is divided into BCAP1/2 and BCU (or BCAP3):

BCAP1/2

Compares Respondent-driven sampling (RDS)and Venue-based sampling (VBS) recruitment in terms of numbers of new diagnosis of HIV+ and examines the effectiveness of peer-driven intervention (PDI) in heterosexuals at high risk (HHR). BCAP2 only includes those who tested HIV+ in BCAP1 who were included in recruitment but not in the main analyses. PDI involving structured intervention sessions including a computerized "CARE for Prevention" tool and HIV pre-test and post-test counseling, the opportunity to educate three peers on core education messages, and navigation for those HIV infected. If HIV-negative: total 3.5 hours of facilitated/computer intervention activities, plus peer education experiences; if HIV-positive: 5 hrs facilitated/computer activities, plus peer education experiences and six months of navigation.

BCU (or BCAP3)

BCU is a supplement study to BCAP1/2 and tests an anonymous, single-session HIV testing intervention (ASTN) in the same high-risk area (HRA) in Brooklyn as BCAP1/2 and compare to CTTN in two phases: the Seek and Test phase (N=750), and Treat and Retain phase (N=65). The primary endpoint of the Seek and Test intervention phase is the relative yield (proportion of newly identified HIV infections) of the RDS-ASTN intervention. The study assesses the proportion of those newly diagnosed that engages in activities of the Treat and Retain part (i.e., feasibility). The primary endpoints for the Treat and Retain intervention phase are the proportion linked to care within three months (i.e., attending a care appointment and receiving CD4 and viral load tests) and time to the HIV care appointment.1 BCU2 only includes those who tested positive in BCU1 who were included in ST counseling sessions and blood collection but not included in TrR phase.

Curated

Partially restricted

Simple Crosstabs

Project STRIDE: Stress, Identity, and Mental Health, New York City, 2004-2005 (ICPSR 35525)

Released/updated on: 2018-11-28

Geographic coverage: New York City

Time period: 2004-01-01--2005-01-01

Project STRIDE is a three-year research project that examines the effect of stress and minority identity related to sexual orientation, race/ethnicity and gender on mental health. The research describes social stressors that affect minority populations, explores the coping and social support resources that they utilize as they confront these social stressors, and assesses the associations of stress and coping with mental health outcomes including mental disorders and wellbeing. The study also explores the impact of various identity characteristics, such as whether an identity is viewed positively or negatively, or whether it is prominent or not to the relationship of stress and mental health outcomes.

The study, using extensive quantitative and some qualitative measures, is a longitudinal survey of 525 men and women between the ages 18 and 59 who are residents of New York City. Socio-demographic information collected about respondents included age, education, race and Hispanic ethnicity, adopting the measures developed and used by the United States Census Bureau in the United States population survey of 2000. In addition to these items, racial/ethnic identity was also assessed with the question "What is the country of origin related to your or your family's ethnic or national background, if any?" Respondents were allowed to select up to two nations from a comprehensive listing. For the purposes of the study, the instrument also assessed whether or not participants were natives of New York City or migrated as adults. Additional demographic variables include employment status, religion, relationship status, and sexual orientation.

Curated

Simple Crosstabs

Risk Factors for AIDS Among Intravenous Drug Users Study, New York City, 1991-1995 (ICPSR 36215)

Released/updated on: 2015-06-30

Geographic coverage: New York City, United States

Time period: 1991-01-01--1995-01-01

The Risk Factors for AIDS among Intravenous Drug Users study is an ongoing series of cross-sectional studies that recruits participants from a storefront research site and from one of New York City's largest detoxification facilities. The goal of the study was to assess the potential effectiveness of HIV interventions by examining participants' drug use, risk behavior, and AIDS prevention knowledge and activities.

The dataset combines survey responses taken from interviews conducted at the Bellevue Methadone Maintenance Treatment Program, the Beth Israel Medical Center and from a high drug use area in Lower East Side of Manhattan. All participants were at least 18 years of age or older. Participants from the Beth Israel Medical Center and the Lower East Side were given face-to-face interviews based on a World Health Organization Multi-Centre questionnaire. Data from the Bellevue Methadone Maintenance Treatment Program were extracted from patients' clinical files. Minimal demographic and HIV risk behavior were included in the methadone patient responses in these data to protect their anonymity. Blood samples were taken from participants to test for HIV.

These data also contain information on topics including participant demographics, alcohol use, drug use, substance abuse treatment, needle sharing habits, sexual behavior, social networks, HIV testing services, as well as mental and physical health. Drugs use explored in this study includes heroin, cocaine, crack, methadone, amphetamines, ice, tranquilizers, barbiturates and other drugs.

This dataset is public-use. A restricted-use version of the dataset is also available with the associated study number 35078. There are 2,907 respondents and 902 variables in the dataset.

Curated

Risk Factors for AIDS Among Intravenous Drug Users Study, New York City, 1991-1995 [Restricted] (ICPSR 35078)

Released/updated on: 2015-02-24

Geographic coverage: New York City, United States

Time period: 1991-01-01--1995-01-01

There are 2,907 respondents and 906 variables in the dataset.

Curated

Restricted

Seek, Test and Retain (STAR): Linkages for Black HIV-Positive, Substance-Using MSM, New York City, 2012-2015 (ICPSR 39794)

Released/updated on: 2026-04-20

Geographic coverage: New York City, United States, New York (state)

Time period: 1989-01-01--2015-01-01

The Seek, Test, Treat and Retain (STTR) Collaboration Project involved over twenty studies in the fields of HIV and drug abuse (a list of the studies is given below).

These studies were independently developed, but were chosen for the collaboration because they focused on one or more steps of the HIV treatment cascade: Seek, Test, Treat and Retain. These studies were grouped into Criminal Justice-related studies and Vulnerable Population-related studies. The data collected by these studies included twelve common domains (eg. Demographic characteristics, Mental Health) in each of which a shared questionnaire or instrument was taken up by the studies and adapted to fit the study.

The STAR study contains information on HIV+ individuals, their emotional well-being, and possible linkages to substance-use.

Curated

Restricted

Seek, Test, Treat and Retain (STTR) Collaboration Project Summary Files, 7 countries, 2010-2017 (ICPSR 39821)

Released/updated on: 2026-07-14

Geographic coverage: Rhode Island, San Juan, Puerto Rico, United States, California, Florida, Kenya, New York (state), India, Russia, New York City, San Francisco, Atlanta, Lima, Illinois, Massachusetts, Connecticut, South Africa, Los Angeles, Georgia, Peru, Maryland, Wisconsin, Vietnam (Socialist Republic)

Time period: 2010-01-01--2017-01-01

This study is part of the Seek, Test, Treat and Retain (STTR) Collaboration Project involved over twenty studies in the fields of HIV and drug abuse. All studies were independently developed, but were chosen for the collaboration because they focused on one or more steps of the HIV treatment cascade: Seek, Test, Treat and Retain. As part of STTR Collaboration Project, the studies were grouped into Criminal Justice-related studies and Vulnerable Population-related studies. The data collected by these studies included twelve common domains (e.g., Demographic characteristics, Mental Health) in each of which a shared questionnaire or instrument was taken up by the studies and adapted to fit the study.

The data in this study focuses on adult respondents' health status and viral load involving HIV and HCV.

Curated

Restricted

START Together: HIV Testing and Treatment In and After Jail, New York, 2011-2014 (ICPSR 39795)

Released/updated on: 2026-05-28

Geographic coverage: New York City, United States, New York (state)

Time period: 2011-01-01--2014-01-01

The overall aim of the START study is to increase the rate of HIV testing among recently released offender populations.

CARE-RAPID (RCT)

This is a pilot randomized study of a computer-assisted program, the Computer Assessment and Risk-Reduction Education--Rapid (CARE-Rapid). CARE-Rapid was used as means of educating offenders leaving jails about the risk of HIV and gaining their consent for an HIV test. The sample consisted of offenders discharged from jails within the past 90 days and entering a residential substance abuse treatment program. The study used an intent-to-treatment design with random assignment to a CARE-Rapid and a treatment-as-usual (TAU) condition. The outcome of interest was whether participants got an HIV test at admission to the treatment program. Participants were followed-up with at 3 months after baseline. CARE-RAPID was conducted at Samaritan Village Inc, a residential substance abuse treatment center, and includes individuals discharged from Riker's Island or Nassau County Jail.

Project START (Quasi-experimental study)

Project START is a quasi-experimental pilot study to evaluate the efficacy of Project START, a manualized intervention focusing on reducing risk for HIV. Project START consisted of two sessions in jail and four sessions during the first three months after discharge from a facility for offenders serving one year or less. The intervention was administered by Exponents, not-for-profit organization that offers a number of services, including outpatient substance abuse treatment. All Project START subjects were offered an HIV test and pre- and post-test counseling on their arrival at Exponents post-discharge from Rikers Island. Participants in Project Start were compared to the experimental arm from CARE-RAPID.

Qualitative Interviews

Qualitative interviews were conducted to gain a better understanding of those aspects of the offender's perceptions and circumstances that facilitate or hinder taking an HIV test. Interviews were with offenders who have been released from New York City and Nassau County Jails in the 90-days prior to entering Exponents for treatment.

Curated

Variations in Criminal Patterns Among Narcotic Addicts in Baltimore and New York City, 1983-1984 (ICPSR 9586)

Released/updated on: 2013-05-15

Geographic coverage: New York City, Baltimore, United States, New York (state), Maryland

Time period: 1983-05-01--1984-04-01

This data collection was undertaken to develop a typology of narcotic addicts according to the kind, frequency, and seriousness of their crimes and to identify the most serious criminal offenders, thereby determining which individuals were best suited to rehabilitation. The following questions are addressed by the data: (1) What "types" of narcotic addicts can be distinguished in terms of their criminal behavior? Which of these types are amenable to rehabilitation? (2) At what time during their addiction careers do addicts commit the most crime? Do narcotic addicts "mature" out of addiction? (3) What is the relationship between individuals' involvement in crime prior to addiction and their criminal activity and drug use over their addiction career? (4) Which demographic, personality, or other factors are associated with serious crime committed during periods of narcotic addiction? (5) What are the contributions of situational and dispositional factors to the relationship between addiction and crime? Part 1 of the collection details the subjects' addiction careers, the age they first used various drugs, the age they first became addicted to narcotics, the amount of time they were addicted/not addicted to narcotics, and the total length of their addiction careers. Part 2 contains variables generated by cluster analysis, including cluster assignment or "type." Part 3 includes the educational, occupational, and arrest histories of the subjects, as well as the drug use and arrest histories of their families. The Part 4 file consists of Minnesota Multiphasic Personality Inventory and Raven Progressive Matrix scores. The frequency and types of crime that subjects committed during the preaddiction period comprise Part 5, while the frequency and nature of drug use during the preaddiction period comprise Part 6. Parts 7 and 8 contain crime variables and drug use variables, respectively, across all nonaddiction periods. Finally, Part 9 contains data characterizing crime across all addiction periods, and Part 10 contains variables regarding drug use across total addiction periods.

Curated

Weekly Variation in Naloxone Possession and Carriage Among People Who Use Opioids in New York City Before and During the COVID-19 Pandemic: A Pre-Post Comparison, 2019-2022 (ICPSR 39341)

Released/updated on: 2025-08-14

Geographic coverage: New York City

Time period: 2019-01-01--2022-01-01

There is a dearth of research examining how naloxone possession and carriage are impacted by time-varying individual and social determinants, including during the COVID-19 pandemic. This study focuses on 40 people from New York City that use illicit opiods and their Naloxone possession and carriage habits during the COVID-19 pandemic.